Chronic Myeloid Leukemia‎

Updated Analysis of Data Demonstrates Efficacy of TFR in Chronic Myeloid Leukemia in Chronic Phase

By

Joyce Pagan

Publish Date April 9, 2021

Researchers report on the feasibility of TFR in patients with CML-CP in updated analysis of the ENESTfreedom study.

Dasatinib, Nilotinib Effective Second-Line Therapy for Chronic Myeloid Leukemia

By

Patricia Chaney

Publish Date April 8, 2021

Researchers sought to determine whether dasatinib and nilotinib would be effective second-line therapies for patients with chronic phase CML.

BCR-ABL1 Kinetics Associated With Long-Term TFR Status in Patients With Chronic Myeloid Leukemia

By

Jessica Nye, PhD

Publish Date March 31, 2021

Researchers sought to determine key determinants of sustained treatment-free remission in patients with CML who have completed TKI treatment in an attempt to develop strategies that achieve long-term remission.

Case Study Shows Potential Protective Effect of TKI Therapy for Chronic Myeloid Leukemia

By

Vicki Moore, PhD

Publish Date March 26, 2021

A case study with a literature review demonstrates potential antiviral effect of TKI therapy in patients with cancer and COVID-19.

Molecular Response Maintained With Intermittent Tyrosine Kinase Inhibitor Regimen in Patients With CML

By

Jessica Nye, PhD

Publish Date March 10, 2021

Results of the ongoing OPTkIMA study comparing a fixed and a progressive TKI plan in patients with CML is discussed.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .